Related Experiment Videos
Bipolar laparoscopic needles for myoma coagulation
1Montclair Reproductive Center, 29 The Crescent, Montclair, NJ 07042, USA.
Summary
A new bipolar needle effectively coagulates symptomatic uterine myomas, comparable to the Nd:YAG laser. This minimally invasive treatment resulted in significant myoma shrinkage and no regrowth at six months.
Area of Science:
- Gynecology
- Minimally Invasive Surgery
- Reproductive Medicine
Background:
- Symptomatic uterine myomas affect many women, impacting quality of life.
- Current treatments for uterine myomas include surgical options and hormonal therapies.
- Laparoscopic coagulation offers a less invasive approach to myoma treatment.
Purpose of the Study:
- To evaluate the clinical effectiveness of a novel bipolar needle for laparoscopic coagulation of symptomatic uterine myomas.
- To compare the efficacy and outcomes of the bipolar needle with the established neodymium:yttrium-aluminum-garnet (Nd:YAG) laser therapy.
Main Methods:
- An observational, comparative study was conducted in a community hospital setting.
- 300 women with symptomatic myomas (≤10 cm) pretreated with depot leuprolide and not desiring future childbearing were included.
- 150 women were treated with Nd:YAG laser, and 150 with the bipolar needle, involving repeated myoma coagulation via multiple passes.
Main Results:
- The bipolar needle treatment led to devascularization and significant shrinkage of uterine myomas, comparable to Nd:YAG laser therapy.
- Endovaginal ultrasound assessed myoma size and location pre-treatment.
- Complications were infrequent, and no myoma regrowth was observed at the 6-month follow-up.
Conclusions:
- The bipolar needle is a safe and effective alternative to Nd:YAG laser for laparoscopic coagulation of symptomatic uterine myomas.
- The procedure achieved a 50% to 70% reduction in myoma size with no evidence of recurrence.
- This technique offers a promising minimally invasive option for managing uterine fibroids.